top of page
Glossary Term
< Return to Main Navigation

Go-To-Market Strategy

Definition

A Go-To-Market (GTM) Strategy is a comprehensive plan that outlines how a company will bring a product to market, attract customers, and achieve competitive advantage. In the MedTech industry, a GTM strategy focuses on navigating regulatory requirements, targeting key stakeholders such as healthcare providers and payers, and optimizing distribution channels to ensure successful adoption of medical devices or technologies.

Relevance to the MedTech Industry

A GTM strategy ensures that MedTech products reach the right audience effectively and compliantly. It addresses the unique challenges of the industry, such as regulatory approval timelines, clinical validation, and reimbursement pathways, while driving market adoption and growth.

Additional Information & Related Terms

Examples of Applications

  • Developing a GTM strategy for a novel wearable health monitor that includes reimbursement plans, key opinion leader (KOL) advocacy, and partnerships with healthcare organizations.

  • Launching a Class II surgical tool in multiple international markets, requiring coordinated regulatory submissions and distributor agreements.

  • Creating a marketing campaign for a diagnostic device targeting healthcare providers and leveraging clinical trial data to demonstrate effectiveness.

Components of a GTM Strategy

  1. Target Market Definition: Identifying the key demographic, clinical segment, or geographic market for the device.

  2. Value Proposition: Highlighting the unique benefits and addressing unmet clinical or operational needs.

  3. Pricing Strategy: Determining competitive yet profitable pricing structures, often considering reimbursement policies.

  4. Distribution Channels: Establishing partnerships with distributors, hospitals, or direct-to-consumer pathways.

  5. Marketing and Sales Plans: Deploying digital, in-person, or conference-driven campaigns to reach stakeholders.

Related Terms

  • Market Access: Securing regulatory and reimbursement approval as part of GTM efforts.

  • Key Opinion Leader (KOL): Influential stakeholders who drive product credibility and adoption.

  • Regulatory Strategy: A component of GTM that ensures alignment with approval processes.

  • Reimbursement Pathway: Addressing payer coverage to ensure product affordability for end-users.

bottom of page